MEDNAX Inc (MD) Releases Earnings Results, Misses Expectations By $-0.04 EPS

MEDNAX Inc (MD) reported quarterly earnings results on Thursday, Jul-28-2016. The company reported $1.03 earnings per share for the quarter, missing the analyst consensus estimate by $-0.04. Analysts had a consensus of $1.07. The company posted revenue of $771.80 million in the period, compared to analysts expectations of $774.46 million. The company’s revenue was up 14.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.90 EPS.

MEDNAX Inc closed down -5.42 points or -7.19% at $69.93 with 39,74,715 shares getting traded on Thursday. Post opening the session at $71.28, the shares hit an intraday low of $67.93 and an intraday high of $72.625 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

In a different news, on Jun 14, 2016, Dominic J Andreano (SVP, General Counsel and Secy) sold 3,922 shares at $68.80 per share price. According to the SEC, on Jun 10, 2016, Md Carlo A Waldemar, (director) sold 5,334 shares at $70.50 per share price. On Jun 8, 2016, Karl B Wagner (President, Eastern Division) sold 27,482 shares at $68.45 per share price, according to the Form-4 filing with the securities and exchange commission.

MEDNAX Inc. (MEDNAX) is a provider of physician services including newborn maternal-fetal and other pediatric subspecialty care. The Company provides clinical care to babies born prematurely or with complications within specific hospital units primarily neonatal intensive care units (NICUs). It provides anesthesia care at more than 90 hospitals 100 ambulatory surgery centers and office-based practices with over 950 of its affiliated anesthesiologists. It provides acute and chronic pain management services in over 20 pain management centers through its network of physicians and physician assistants. It provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its over 245 affiliated maternal-fetal medicine subspecialists as well as obstetricians and other clinicians. Its network includes other pediatric subspecialists such as pediatric intensivists pediatric hospitalists and pediatric surgeons.


Leave a Reply

MEDNAX Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on MEDNAX Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.